Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cancer drug sigvotatug vedotin enters human trials

NCT ID NCT04389632

Disease control Sponsor: Seagen, a wholly owned subsidiary of Pfizer Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This early-stage trial is testing a new drug called sigvotatug vedotin, alone or with other cancer medicines, in people with advanced solid tumors like lung, head and neck, and breast cancers. The study aims to find a safe dose and check for side effects. About 1,000 participants will take part across four parts of the study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
sigvotatug vedotin (SGN-B6A)
What this could lead to
If it works, this could point toward a new treatment option for several advanced solid tumors that are hard to treat.
What could go wrong
This is an early phase 1 trial, so the main goal is safety, not proof of effectiveness. The drug may cause side effects or not work as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

About 1,006 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2020

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Disease indication * Participants must have histologically or cytologically confirmed metastatic or unresectable solid malignancy within one of the tumor types listed below (dependent on study part). * Non-small cell lung cancer (NSCLC) * Head and neck squamous cell cancer (HNSCC) * Advanced HER2-negative breast cancer * Esophageal squamous cell carcinoma (ESCC) * Esophageal/Gastro-esophageal junction adenocarcinoma (EAC/GEJ) * Cutaneous squamous cell cancer (cSCC) * Exocrine pancreatic adenocarcinoma * Bladder cancer * Cervical cancer * Gastric cancer * High grade serous ovarian cancer (HGSOC) * Part A only: Participants must have disease that is relapsed or refractory or be intolerant to standard-of-care therapies and should have no appropriate standard-of-care therapeutic options. * Part B only: Participants must have disease that is relapsed or refractory or be intolerant to standard-of-care therapies. Participants must have received platinum-based therapy and a PD-1/PD-(L)1 inhibitor, if applicable and available. * Part C only: For pembrolizumab combination cohorts, participants must be eligible for pembrolizumab per local standard of care. For pembrolizumab with cisplatin or carboplatin, participants must be eligible for both pembrolizumab and the platinum agent per local standard of care. Participants must be treatment naïve for locally advanced or metastatic systemic therapy (prior definitively intended or \[neo\]adjuvant therapy is allowed). * Part D only: Participants must be treatment naïve for locally advanced or metastatic systemic therapy. * Participants enrolled in the following study parts should have a tumor site accessible for biopsy and agree to biopsy as follows: * Disease-specific expansion cohorts (Part B and Part D): A baseline fresh tumor biopsy is required. An archival biopsy collected within 90 days prior to first dose of study drug may be used. * Biology expansion cohort: pretreatment biopsy and on-treatment (Cycle 1) biopsy * An Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 * Measurable disease per the RECIST v1.1 at baseline Exclusion Criteria * History of another malignancy within 3 years before first dose of study drug, or any evidence of residual disease from a previously diagnosed malignancy. Exceptions are malignancies with a negligible risk of metastasis or death. * Known active central nervous system metastases. Participants with previously treated brain metastases may participate provided they: * are clinically stable for at least 4 weeks prior to study entry after brain metastasis treatment, * have no new or enlarging brain metastases, and * are off of corticosteroids prescribed for symptoms associated with brain metastases for at least 7 days prior to first dose of study drug. * In Part D, participants with untreated, asymptomatic CNS metastases smaller than 1 cm may be enrolled without definitive treatment as long as they have no neurological symptoms, no or minimal surrounding edema, and no requirements for corticosteroids. * Carcinomatous meningitis * Previous receipt of an MMAE-containing agent or an agent targeting integrin beta-6 * Pre-existing neuropathy Grade 1 or greater per the National Cancer Institute's Common Terminology Criteria for Adverse Events, version 5.0 (NCI CTCAE v5.0) for Parts C and D cohorts with cisplatin or carboplatin; Grade 2 or greater per the NCI CTCAE v5.0 for all other cohorts * Any uncontrolled Grade 3 or higher (per NCI CTCAE v5.0) viral, bacterial, or fungal infection within 2 weeks prior to the first dose of sigvotatug vedotin. * Routine antimicrobial prophylaxis is permitted * Grade ≥3 pulmonary disease unrelated to underlying malignancy. This includes clinically severe pulmonary function compromise resulting from clinically significant pulmonary illnesses * Part C and D: Prior therapy with a PD-1 inhibitor, anti-PD-(L)1, or anti PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor and was discontinued from that treatment due to a Grade 3 or higher immune-mediated adverse event (IMAE). * History of noninfectious interstitial lung disease (ILD) or pneumonitis that required steroids, current ILD or pneumonitis, or suspected ILD or pneumonitis that cannot be ruled out by imaging at screening * Known diffusing capacity of the lung for carbon monoxide (DLCO; adjusted for hemoglobin) \<50% predicted * Investigator site staff directly involved in the conduct of the study and their family members, site staff otherwise supervised by the investigator, and sponsor and sponsor delegate employees directly involved in the conduct of the study and their family members.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Adenocarcinoma Of Esophagus cervical cancer esophageal adenocarcinoma Esophageal Neoplasms esophageal squamous cell carcinoma exocrine pancreatic carcinoma gastric cancer gastric neoplasm gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma Her2-receptor negative breast cancer non-small cell lung carcinoma ovarian cancer ovarian neoplasm ovarian serous adenocarcinoma pancreatic adenocarcinoma skin squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck urinary bladder carcinoma urinary bladder neoplasm Urinary Bladder Neoplasms Uterine Cervical Neoplasms uterine cervix neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carcinoma, non-small-cell lung Cutaneous squamous cell cancer Esophageal adenocarcinoma Esophageal squamous cell carcinoma Exocrine pancreatic adenocarcinoma Gastroesophageal junction adenocarcinoma HER2 negative breast neoplasms Ovarian neoplasms Squamous cell carcinoma of head and neck Stomach neoplasms Urinary bladder neoplasms Uterine cervical neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    155 sites in 7 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alaska Oncology and Hematology

    RECRUITING

    Anchorage, Alaska, 99508, United States

  • Allina Health Cancer Institute

    RECRUITING

    Saint Paul, Minnesota, 55102, United States

  • Allina Health Cancer Institute - Abbott Northwestern Hospital

    RECRUITING

    Minneapolis, Minnesota, 55407, United States

  • Allina Health Cancer Institute - Mercy Hospital

    RECRUITING

    Coon Rapids, Minnesota, 55433, United States

  • Allina Health Cancer Institute - United Hospital

    RECRUITING

    Saint Paul, Minnesota, 55102, United States

  • American Oncology Network Vista Oncology Division-East office

    RECRUITING

    Olympia, Washington, 98506, United States

  • American Oncology Network Vista Oncology Division-West office

    RECRUITING

    Olympia, Washington, 98502, United States

  • American Oncology Partners, PA. a Florida professional service corporation, d/b/a Vista Oncology

    RECRUITING

    Fort Myers, Florida, 33913, United States

  • Area general-Planta Baixa | Unitat d'investigacio en terapia Molecular del Cancer "la Caixa"

    RECRUITING

    Barcelona, 08035, Spain

  • Beth Israel Deaconess Medical Center

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Beth Israel Deaconess Medical Center,East Campus Research Pharmacy

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Brigham & Women's Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

  • CHUV - Service de pharmacie BH-04, Essais cliniques

    RECRUITING

    Lausanne, CH-1011, Switzerland

  • Cancer AND Blood Specialty Clinic

    NOT_YET_RECRUITING

    Torrance, California, 90505, United States

  • Cancer and Blood Research Center, LLC

    NOT_YET_RECRUITING

    Los Alamitos, California, 90720, United States

  • Cancer and Blood Specialty Clinic

    NOT_YET_RECRUITING

    Los Alamitos, California, 90720, United States

  • Center Hospitalier Universitaire d' Angers

    ACTIVE_NOT_RECRUITING

    Angers, 49100, France

  • Centre Hospitalier Universitaire de Poitiers

    RECRUITING

    Poitiers, 86021, France

  • Centre de Lutte contre le Cancer (CLCC) - Centre Antoine Lacassagne

    RECRUITING

    Nice, 06189, France

  • Chungbuk National University Hospital

    RECRUITING

    Cheongju-si, North Chungcheong, 28644, South Korea

  • Columbia University Irving Medical Center

    RECRUITING

    New York, New York, 10032, United States

  • Community Health Network Investigational Drug Services

    RECRUITING

    Indianapolis, Indiana, 46250, United States

  • Community Health Network, Inc

    RECRUITING

    Indianapolis, Indiana, 46219, United States

  • Community Health Network, Inc.

    RECRUITING

    Indianapolis, Indiana, 46227, United States

  • Community Health Network, Inc.

    RECRUITING

    Indianapolis, Indiana, 46250, United States

  • Comprehensive Cancer Centers of Nevada

    RECRUITING

    Las Vegas, Nevada, 89169, United States

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Dana-Farber Cancer Institute - Chestnut Hill

    RECRUITING

    Newton, Massachusetts, 02467, United States

  • Diagnostic centre

    RECRUITING

    London, W1G 7AF, United Kingdom

  • Elche General University Hospital

    RECRUITING

    Elche, Alicante, 03203, Spain

  • Elche General University Hospital

    RECRUITING

    Elche, Valencia, 03203, Spain

  • Elche General University Hospital

    RECRUITING

    Elche, 03203, Spain

  • Equipo de Farmacia Oncológica- Ensayos Clínicos Servicio de Farmacia Hospital Universitario Marqués

    RECRUITING

    Santander, Cantabria, 39008, Spain

  • Exigent Research, LLC

    RECRUITING

    Tacoma, Washington, 98405, United States

  • Farmacia Ensayos Hospital HM Universitario Sanchinarro

    RECRUITING

    Madrid, Agrigento, 28050, Spain

  • Farmacia Ensayos clínicos, Unidad START Barcelona

    RECRUITING

    Barcelona, 08023, Spain

  • Florida Cancer Specialists

    RECRUITING

    Orlando, Florida, 32827, United States

  • Florida Cancer Specialists & Research Institute, LLC

    RECRUITING

    Fort Myers, Florida, 33916, United States

  • Fort Wayne Medical Oncology and Hematology, Inc

    RECRUITING

    Fort Wayne, Indiana, 46804, United States

  • Fundación Privada Instituto de Investigación Oncológica de Vall Hebron

    RECRUITING

    Barcelona, Other, 08035, Spain

  • Fundación de Investigación Hm Hospitales, C.I.F. G-83643841

    RECRUITING

    Madrid, 28015, Spain

  • Highlands Oncology Group

    RECRUITING

    Fayetteville, Arkansas, 72703, United States

  • Highlands Oncology Group

    RECRUITING

    Rogers, Arkansas, 72758, United States

  • Highlands Oncology Group

    RECRUITING

    Springdale, Arkansas, 72762, United States

  • Hospital General Universitario de Elche

    RECRUITING

    Elche, Valencia, 03203, Spain

  • Hospital HM Nou Delfos

    RECRUITING

    Barcelona, Catalonia, 08023, Spain

  • Hospital HM Nou Delfos - START Barcelona

    RECRUITING

    Barcelona, 08023, Spain

  • Hospital HM Sanchinarro, START-Madrid-CIOCC

    RECRUITING

    Madrid, 28050, Spain

  • Hospital Quiron Salud Barcelona

    RECRUITING

    Barcelona, 08023, Spain

  • Hospital Universitario 12 Octubre

    RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitario De Jerez

    RECRUITING

    Jerez de la Frontera, 10407, Spain

  • Hospital Universitario Marques de Valdecilla

    RECRUITING

    Santander, Cantabria, 39008, Spain

  • Hospital Universitario Ramon y Cajal

    RECRUITING

    Madrid, 28034, Spain

  • Hospital Universitario de Jerez

    RECRUITING

    Jerez de la Frontera, 11407, Spain

  • Hospital Vall d'Hebron

    RECRUITING

    Barcelona, 08035, Spain

  • Houston Medical Imaging

    NOT_YET_RECRUITING

    Pearland, Texas, 77581, United States

  • Ingalls Family Care Center

    RECRUITING

    Calumet City, Illinois, 60409, United States

  • Institut Gustave Roussy Department de Pharmacie Clinique(-1)

    RECRUITING

    Villejuif, 94805., France

  • Institut de Cancérologie de Lorraine

    RECRUITING

    Vandœuvre-lès-Nancy, 54519, France

  • Kantonsspital Graubunden

    RECRUITING

    Chur, 7000, Switzerland

  • Kaohsiung Medical University Hospital

    RECRUITING

    Kaohsiung City, R.o.c., 80756, Taiwan

  • Korea University Guro Hospital

    RECRUITING

    Seoul, 08308, South Korea

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • Memorial Cancer Institute

    RECRUITING

    Hollywood, Florida, 33021, United States

  • Memorial Cancer Institute at Memorial Hospital West

    RECRUITING

    Pembroke Pines, Florida, 33028, United States

  • Memorial Healthcare System

    RECRUITING

    Hollywood, Florida, 33021, United States

  • Memorial Hospital West

    RECRUITING

    Pembroke Pines, Florida, 33028, United States

  • NEXT Oncology Barcelona - IOB - Hospital Quironsalud Barcelona

    RECRUITING

    Barcelona, OTH, 08023, Spain

  • National Cancer Center

    RECRUITING

    Goyang-si, Gyeonggi-do, 10408, South Korea

  • National Taiwan University Hospital

    RECRUITING

    Taipei, 100, R.O.C, Taiwan

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists

    RECRUITING

    Babylon, New York, 11702, United States

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists

    RECRUITING

    Brooklyn, New York, 11210, United States

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists

    RECRUITING

    New Hyde Park, New York, 11042, United States

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists

    RECRUITING

    New York, New York, 10028, United States

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists

    RECRUITING

    Patchogue, New York, 11772, United States

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists

    RECRUITING

    Port Jefferson Station, New York, 11776, United States

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists

    RECRUITING

    Riverhead, New York, 11901, United States

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists

    RECRUITING

    Shirley, New York, 11967, United States

  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists

    RECRUITING

    The Bronx, New York, 10469, United States

  • Northwest Medical Specialities, PLLC

    NOT_YET_RECRUITING

    Tacoma, Washington, 98405, United States

  • Northwest Medical Specialities. PLLC

    NOT_YET_RECRUITING

    Bonney Lake, Washington, 98391, United States

  • Northwest Medical Specialities. PLLC

    NOT_YET_RECRUITING

    Gig Harbor, Washington, 98332, United States

  • Northwest Medical Specialities.PLLC

    NOT_YET_RECRUITING

    Federal Way, Washington, 98003, United States

  • Northwest Medical Specialties, PPLC

    NOT_YET_RECRUITING

    Puyallup, Washington, 98373, United States

  • OU Health University of Oklahoma Medical Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • Oncology Consultants, PA

    RECRUITING

    Houston, Texas, 77024, United States

  • Oncology Consultants, PA.

    RECRUITING

    Houston, Texas, 77030, United States

  • Providence Cancer Institute Franz Clinic

    RECRUITING

    Portland, Oregon, 97213, United States

  • Providence Medical Foundation

    RECRUITING

    Anaheim, California, 92805, United States

  • Providence Medical Foundation

    RECRUITING

    Fullerton, California, 92835, United States

  • Providence Oncology and Hematology Care Clinic - Westside

    RECRUITING

    Portland, Oregon, 97225, United States

  • Providence St. Jude Medical Center Virginia K Crosson and Infusion Center

    RECRUITING

    Fullerton, California, 92835, United States

  • Providence St. Vincent Medical Center

    RECRUITING

    Portland, Oregon, 97225, United States

  • Providence St. Vincent Medical Center- Investigational Drug Services

    RECRUITING

    Portland, Oregon, 97225, United States

  • Queen Elizabeth Hospital

    RECRUITING

    Birmingham, B15 2TH, United Kingdom

  • Quironsalud Malaga

    RECRUITING

    Málaga, 129004, Spain

  • Radiology

    RECRUITING

    London, W1G 8PP, United Kingdom

  • Ronald Reagan UCLA Medical Center

    RECRUITING

    Los Angeles, California, 90095, United States

  • Royal Marsden Hospital

    RECRUITING

    Sutton, Surrey, SM2 5PT, United Kingdom

  • Sanford Cancer Center

    RECRUITING

    Sioux Falls, South Dakota, 57104, United States

  • Sanford USD Medical Center

    RECRUITING

    Sioux Falls, South Dakota, 57105, United States

  • Sarah Cannon Research Institute

    RECRUITING

    London, W1G 6AD, United Kingdom

  • Seoul Metropolitan Government Seoul National University Boramae Medical Center

    RECRUITING

    Seoul, 07061, South Korea

  • Servicio de Radiologia Hospital Universitario Ramon y Cajal

    RECRUITING

    Madrid, 28034, Spain

  • Severance Hospital Yonsei University Health System

    RECRUITING

    Seoul, 03722, South Korea

  • South Texas Accelerated Research Therapeutics, LLC

    ACTIVE_NOT_RECRUITING

    San Antonio, Texas, 78229, United States

  • Southern Illinois University - Simmons Cancer Institute

    RECRUITING

    Springfield, Illinois, 62702, United States

  • Springfield Clinic

    RECRUITING

    Springfield, Illinois, 62702, United States

  • Springfield Clinic Main Campus

    RECRUITING

    Springfield, Illinois, 62703, United States

  • Springfield Clinic Radiology - 800 Building

    RECRUITING

    Springfield, Illinois, 62702, United States

  • Springfield Clinic Radiology - Main Campus

    RECRUITING

    Springfield, Illinois, 62703, United States

  • Springfield Clinic Urgent Care Plus

    RECRUITING

    Springfield, Illinois, 62702, United States

  • Springfield Memorial Hospital

    RECRUITING

    Springfield, Illinois, 62781, United States

  • Stephenson Cancer Center (chemo location)

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • Swedish Cancer Institute

    RECRUITING

    Seattle, Washington, 98104, United States

  • Swedish Cancer Institute - Edmonds Campus

    RECRUITING

    Edmonds, Washington, 98026, United States

  • Swedish Cancer Institute Edmonds Campus

    RECRUITING

    Edmonds, Washington, 98026, United States

  • Swedish Medical Center

    RECRUITING

    Seattle, Washington, 98122, United States

  • Taipei Veterans General Hospital.

    RECRUITING

    Taipei, 11217, Taiwan

  • The Catholic University of Korea

    RECRUITING

    Seoul, 06591, South Korea

  • The Harley Street Clinic

    RECRUITING

    London, W1G 8BJ, United Kingdom

  • The Regents of the University of California

    RECRUITING

    Los Angeles, California, 90095, United States

  • The Royal Marsden Hospital (Surrey)

    RECRUITING

    Sutton, Queensland, SM2 5PT, United Kingdom

  • The Royal Marsden NHS Foundation Trust

    RECRUITING

    London, SW3 6JJ, United Kingdom

  • The University Of Chicago

    RECRUITING

    Chicago, Illinois, 60637, United States

  • The University of Chicago Medicine Center for Advanced Care Orland Park

    RECRUITING

    Orland Park, Illinois, 60462, United States

  • The University of Kansas Cancer Center - Indian Creek Campus

    RECRUITING

    Overland Park, Kansas, 66211, United States

  • The University of Kansas Cancer Center - Westwood

    RECRUITING

    Westwood, Kansas, 66205, United States

  • The University of Kansas Cancer Center, Investigational Drug Services

    RECRUITING

    Fairway, Kansas, 66205, United States

  • The University of Kansas Clinical Research Center

    RECRUITING

    Fairway, Kansas, 66205, United States

  • The University of Kansas Hospital

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • The University of Kansas Medical Center Medical Office Building

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • The University of Texas M.D. Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • Tranquil Clinical Research

    NOT_YET_RECRUITING

    Webster, Texas, 77598, United States

  • UCLA Department of Medicine - Hematology & Oncology

    RECRUITING

    Santa Monica, California, 90404, United States

  • UCLA Department of Medicine-Hematology/Oncology

    RECRUITING

    Los Angeles, California, 90095, United States

  • UChicago Medicine - Northwest Indiana

    RECRUITING

    Crown Point, Indiana, 46307, United States

  • UChicago Medicine - River East

    RECRUITING

    Chicago, Illinois, 60611, United States

  • UChicago Medicine Ingalls Memorial

    RECRUITING

    Harvey, Illinois, 60426, United States

  • UChicago Medicine at Ingalls - Flossmoor

    RECRUITING

    Flossmoor, Illinois, 60422, United States

  • UChicago Medicine at Ingalls - Tinley Park

    RECRUITING

    Tinley Park, Illinois, 60477, United States

  • UGC Farmacia Ensayos clinicos - Hospital Universitario de Jerez

    RECRUITING

    Jerez de la Frontera, 10407, Spain

  • US Oncology Investigational Product Center (IPC)

    RECRUITING

    Irving, Texas, 75063, United States

  • US Oncology Research LLC

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • UT Health East Texas HOPE Cancer Center

    RECRUITING

    Tyler, Texas, 75701, United States

  • UT Health East Texas Hope Cancer Center

    RECRUITING

    Tyler, Texas, 75708, United States

  • University Hospital Lausanne CHUV

    RECRUITING

    Lausanne, 1011, Switzerland

  • University Hospitals Birmingham NHS Foundation Trust

    RECRUITING

    Birmingham, B15 2TH, United Kingdom

  • University Hospitals Cleveland Medical Center

    ACTIVE_NOT_RECRUITING

    Cleveland, Ohio, 44106, United States

  • University of Chicago Comprehensive Cancer Center at Silver Cross Hospital

    RECRUITING

    New Lenox, Illinois, 60451, United States

  • University of Chicago Medical Center

    RECRUITING

    Chicago, Illinois, 60637, United States

  • University of Kansas Cancer Center

    RECRUITING

    Westwood, Kansas, 66205, United States

  • University of Kansas Hospital Cambridge North Tower A

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Kansas Medical Center Research Institute

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Oklahoma Health Science Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • Virginia Cancer Specialists

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • lnstitut Gustave Roussy, Departement d'lnnovation Therapeutique et d'Essais Precoces (DITEP)

    RECRUITING

    Villejuif, 94805., France

More trials for these conditions

Other studies related to the condition(s) this trial covers.